Health In Tech, Inc. cash flow statement

In fiscal 2025, Health In Tech, Inc.'s operations generated $3.1m of cash.

Cash flow statement

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Health In Tech, Inc.: cash flow statement, annual
Fiscal year	2023Dec 2023	2024Dec 2024	2025Dec 2025	LTMJun 2026
Cash from operations	1,529	2,176	3,134	−5,106
Depreciation and amortisation	339	541	901	1,352
Stock-based pay	—	468	1,570	1,695
Shares issued	—	8,214	—	—

US$ thousands unless shown otherwise. Fiscal quarters.

Health In Tech, Inc.: cash flow statement, quarterly
Quarter	2024 Q3Sept 2024	2024 Q4Dec 2024	2025 Q1Mar 2025	2025 Q2Jun 2025	2025 Q3Sept 2025	2025 Q4Dec 2025	2026 Q1Mar 2026	2026 Q2Jun 2026
Cash from operations	2,121	−531	527	1,481	674	451	−3,319	−2,912
Depreciation and amortisation	136	136	136	136	218	411	403	320
Stock-based pay	—	—	493	708	293	77	367	959
Shares issued	—	—	8,214	0	0	—	6,381	0

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Head to head: HIT vs XHG HIT vs RDZN EZRA vs HIT

More: Insurance Brokers stocks compared, Financials sector, rankings of US companies

Figures from Health In Tech, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Health In Tech, Inc.